Javelin Biotech

Javelin Biotech is a San Diego-based private company founded in 2014, operating at the intersection of drug delivery and biologics. Its core offering is the Javelin Platform, an integrated system of human tissue chips and digital twin software designed to model human physiology and predict drug responses more accurately than traditional animal models. The company targets biopharmaceutical clients with a platform-as-a-service or product-based business model, seeking to reduce late-stage clinical attrition by providing human-relevant data earlier in the drug development process. Leadership includes veterans with experience in major government-funded organ-on-chip initiatives.

Integrated organ-on-a-chip (microphysiological systems) platform combined with digital twin software to model human physiology and predict drug responses.

Javelin operates in the competitive organ-on-a-chip and advanced preclinical models sector, competing with companies like Emulate, CN Bio, and Mimetas, as well as initiatives from large life science tools firms. Its differentiation hinges on its integrated 'digital twin' software and team expertise from major government consortia.